When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
Keywords: iron; red blood cell transfusion [complications]; haemosiderosis; myelodysplastic syndromes; chelation therapy; deferasirox; deferoxamine; deferiprone